Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Submitted by
admin
on June 23, 2011 - 9:12am
Source:
Bloomberg
News Tags:
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
Headline:
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Do Not Allow Advertisers to Use My Personal information
